title: Piscine Reovirus (PRV)
description: Learn about Piscine Reovirus (PRV) in aquaculture fish like Atlantic salmon. Characterized by heart and skeletal muscle inflammation and jaundice syndrome, PRV affects salmonid species and leads to severe economic losses. Discover symptoms, causes, diagnosis, treatment, and prevention strategies for better fish health.
tags:
- PiscineReovirus
- Virus
- ViralDisease
- Salmonoids
- Salmon
- AtlanticSalmon
- ChinookSalmon
- Trout
- RainbowTrout
- Canada
- Scotland
- Chile
- Japan
Piscine Reovirus (PRV)
Piscine Orthoreovirus (PRV) is a viral pathogen that primarily affects salmonid species, including Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), and Pacific salmon species. PRV is associated with diseases such as Heart and Skeletal Muscle Inflammation (HSMI) in farmed Atlantic salmon and jaundice syndrome in Chinook salmon. First identified in Norway in the 1990s, PRV has since been detected in many aquaculture regions worldwide, including Canada, Scotland, Chile, and Japan 13.
Progression of Symptoms
Early Stages: Mild signs such as reduced feed intake and slight lethargy.
Advanced Stages: More pronounced physical symptoms like inflammation and internal lesions.
Impact on Fish Health: PRV infections can compromise immune function and overall vitality, potentially increasing susceptibility to secondary infections 3.
Etiology
Causative Agent: Piscine Orthoreovirus (PRV), a double-stranded RNA virus with three known genotypes: PRV-1, PRV-2, and PRV-3 3.
Transmission Methods:
Risk Factors
Environmental Factors: Stress conditions may precipitate clinical disease 1.
Farm Management Practices: High-density aquaculture settings may facilitate virus spread.
Diagnostic Methods
Clinical Examination: Observation of physical and behavioral symptoms indicative of PRV infection.
Laboratory Tests:
Differential Diagnosis
Treatment Options
Preventive Measures
Real-World Examples
Notable Findings:
Research Outcomes:
These findings highlight the complex nature of PRV infections and the need for continued research to fully understand its impact on different salmonid species and populations.
PRV Incidence in Canada:
Geographical Spread:
Economic Impact:
Treatment & Management:
PRV Incidence in Norway:
Geographical Spread:
Economic Impact:
Treatment & Management:
Recent studies on PRV in salmonids have focused on various aspects of the disease, including its prevention, control, and economic impact. Here are some notable recent research findings:
These studies represent advancements in understanding the prevention, control, and economic impact of PRV in various regions, particularly in Norway and other countries with significant salmon farming industries.
Piscine Reovirus (PRV) remains a significant challenge for aquaculture, necessitating diligent management and preventive measures. By implementing robust biosecurity protocols, investing in ongoing research, and fostering industry-wide cooperation, fish health managers and veterinarians can mitigate the impact of PRV and ensure the sustainability of aquaculture operations. This comprehensive guide aims to provide the necessary information and resources to effectively manage PRV and support the health and welfare of farmed fish.
For more information on managing fish diseases and enhancing fish health, subscribe to our newsletter and follow our latest research updates.
Last Modified: 2024-07-26
Tags: #PiscineReovirus, #PRV, #HSMI, #Salmonoids, #Salmon, #AtlanticSalmon, #Trout, #RainbowTrout, #Norway, #Chile, #Canada, #Scotland, #FaroeIslands, #ViralDisease, #Virus
Cardiomyopathy Syndrome (CMS)
Heart and Muscle Inflammation (HSMI)
Infectious Pancreatic Necrosis (IPN)
Infectious Salmon Anemia (ISA)
Pancreatic Disease (PD)
Citations:
[1] https://www.adfg.alaska.gov/static/species/disease/pdfs/fishdiseases/piscine_orthoreovirus.pdf
[2] https://www.dfo-mpo.gc.ca/science/aah-saa/species-especes/aq-health-sante/prv-rp-eng.html
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384080/
[4] https://www.dnr.wa.gov/sites/default/files/publications/PRV%20whitepaper%20revised%20Sept%202017.pdf
[5] https://virologyj.biomedcentral.com/articles/10.1186/s12985-019-1148-2
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425399/
[7] https://www.nature.com/articles/s41598-019-40025-7